id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-P-0151-0001,FDA,FDA-2000-P-0151,FDA/DDM to Satori Food Corp.,Other,ACK-Acknowledgement Letter,2000-12-29T05:00:00Z,2000,12,,,2008-04-25T01:31:51Z,,0,0,09000064804d117d
FDA-2000-D-0598-0002,FDA,FDA-2000-D-0598,Guidance for Industry #116 Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies VICH GL23; Draft Guidance,Other,Guidance,2000-12-18T05:00:00Z,2000,12,2013-01-23T05:00:00Z,,2013-01-24T03:08:44Z,,0,0,09000064804dd8b1
FDA-2000-P-1559-0001,FDA,FDA-2000-P-1559,FDA/DDM to Center for Science in the Public Interest (CSPI),Other,ACK-Acknowledgement Letter,2000-12-13T05:00:00Z,2000,12,,,2008-04-25T01:56:32Z,,0,0,09000064804f9287
FDA-2000-D-0028-0002,FDA,FDA-2000-D-0028,Guidance for Industry: Channels of Trade Policy for Commodities with Methyl Parathion Residues,Other,Guidance,2000-11-30T05:00:00Z,2000,11,2020-09-30T04:00:00Z,,2024-11-12T23:25:43Z,,1,0,09000064848a2c00
FDA-1998-P-0046-0001,FDA,FDA-1998-P-0046,FDA/CDRH to Arnold Levin,Other,PDN-Petition Denial,2000-11-08T05:00:00Z,2000,11,,,2008-05-16T21:47:38Z,,0,0,090000648056e6a9
FDA-2000-P-0212-0001,FDA,FDA-2000-P-0212,New Jersey General Assembly - Citizen Petition,Other,CP-Citizen Petition,2000-11-06T05:00:00Z,2000,11,,,2010-08-12T19:47:56Z,,0,0,09000064804d4d1b
FDA-2000-P-0025-0003,FDA,FDA-2000-P-0025,Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association,Other,PAV-Petition Approval,2000-10-31T05:00:00Z,2000,10,,,2024-07-29T20:17:20Z,,0,0,09000064804aea11
FDA-2000-P-0025-0002,FDA,FDA-2000-P-0025,Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association,Other,PAV-Petition Approval,2000-10-31T05:00:00Z,2000,10,,,2024-07-29T20:14:37Z,,0,0,09000064804aea10
FDA-2000-P-0153-0001,FDA,FDA-2000-P-0153,"FDA/DDM to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2000-10-16T04:00:00Z,2000,10,,,2008-04-25T01:45:52Z,,0,0,09000064804d1408
FDA-2000-P-0096-0002,FDA,FDA-2000-P-0096,FDA/DDM to Arnold & Porter,Other,ACK-Acknowledgement Letter,2000-10-02T04:00:00Z,2000,10,,,2008-04-25T01:01:16Z,,0,0,09000064804b8220
FDA-2000-P-0096-0001,FDA,FDA-2000-P-0096,FDA/DDM to Arnold & Porter,Other,ACK-Acknowledgement Letter,2000-10-02T04:00:00Z,2000,10,,,2008-04-25T01:01:17Z,,0,0,09000064804b8209
FDA-2000-P-0214-0001,FDA,FDA-2000-P-0214,"FDA/DDM to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2000-08-22T04:00:00Z,2000,8,,,2008-04-25T01:14:23Z,,0,0,09000064804d4e50
FDA-2000-P-0211-0003,FDA,FDA-2000-P-0211,FDA/CBER to Mark S. Zaid,Other,LET-Letter,2000-08-16T04:00:00Z,2000,8,,,2008-04-25T01:47:40Z,,0,0,09000064804d4cd2
FDA-2000-P-0211-0002,FDA,FDA-2000-P-0211,FDA/CBER to Mark S. Zaid,Other,LET-Letter,2000-08-16T04:00:00Z,2000,8,,,2008-04-25T01:47:40Z,,0,0,09000064804d4cd0
FDA-1980-N-0074-0071,FDA,FDA-1980-N-0074,HFD-560,Other,MM-Memorandum of Meeting,2000-08-09T04:00:00Z,2000,8,,,2008-05-30T22:52:54Z,,0,0,09000064805bb4d0
FDA-1978-N-0018-0439,FDA,FDA-1978-N-0018,Memorandum of Meeting Between FDA/CDER and External Participants,Other,Memorandum,2000-08-07T04:00:00Z,2000,8,,,2019-08-06T19:13:07Z,,0,0,090000648055a6cc
FDA-1978-N-0018-0438,FDA,FDA-1978-N-0018,Memorandum of Meeting Between FDA/CDER Participants and External Participants,Other,Memorandum,2000-08-07T04:00:00Z,2000,8,,,2019-08-06T18:35:41Z,,0,0,090000648055a6c9
FDA-2020-D-1956-0001,FDA,FDA-2020-D-1956,Guidance for Industry: Action Levels for Poisonous or Deleterious Substances in Human Food and Animal Feed,Other,Guidance,2000-07-31T04:00:00Z,2000,7,2020-09-21T04:00:00Z,,2024-11-12T23:24:59Z,,1,0,090000648486938e
FDA-2000-P-0024-0002,FDA,FDA-2000-P-0024,"FDA/DDM to Pharmaceutical Associates, Inc",Other,ACK-Acknowledgement Letter,2000-07-26T04:00:00Z,2000,7,,,2008-04-25T01:13:49Z,,0,0,09000064804ae9ff
FDA-1999-H-0116-0001,FDA,FDA-1999-H-0116,Office of Tobacco Programs,Other,LET-Letter,2000-07-18T04:00:00Z,2000,7,,,2009-07-07T18:08:47Z,,0,0,09000064804ae912
FDA-1999-H-0143-0001,FDA,FDA-1999-H-0143,Office of Tobacco Programs,Other,LET-Letter,2000-07-18T04:00:00Z,2000,7,,,2009-07-07T18:13:38Z,,0,0,09000064804aef05
FDA-1999-H-0018-0001,FDA,FDA-1999-H-0018,Office of Tobacco Programs,Other,LET-Letter,2000-07-12T04:00:00Z,2000,7,,,2009-07-07T14:12:12Z,,0,0,09000064804a5a99
FDA-1999-H-0017-0001,FDA,FDA-1999-H-0017,Office of Tobacco Programs,Other,LET-Letter,2000-07-12T04:00:00Z,2000,7,,,2009-07-07T13:29:31Z,,0,0,09000064804a5a88
FDA-1999-H-0017-0002,FDA,FDA-1999-H-0017,FDA/CDRH/GCF,Other,CR-Correction,2000-07-12T04:00:00Z,2000,7,,,2009-07-07T14:01:38Z,,0,0,09000064804a5a91
FDA-1999-H-0054-0001,FDA,FDA-1999-H-0054,Office of Tobacco Programs,Other,LET-Letter,2000-07-07T04:00:00Z,2000,7,,,2009-07-07T14:13:40Z,,0,0,09000064804a61a3
FDA-1980-N-0074-0070,FDA,FDA-1980-N-0074,HFD-560,Other,MM-Memorandum of Meeting,2000-06-28T04:00:00Z,2000,6,,,2008-05-30T22:53:02Z,,0,0,09000064805bb4cf
FDA-1999-H-0071-0001,FDA,FDA-1999-H-0071,HHS/FDA/CDER Notice of Correction of Store Name - Correction,Other,CR-Correction,2000-06-15T04:00:00Z,2000,6,,,2013-07-27T20:58:49Z,,0,0,09000064804a6880
FDA-1995-S-0039-0320,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,Report,2000-05-21T04:00:00Z,2000,5,2014-02-28T05:00:00Z,,2016-09-30T14:25:01Z,,0,0,090000648055c40f
FDA-1980-N-0074-0069,FDA,FDA-1980-N-0074,"HFD-560, CDER HFD-105 and Warner Lambert",Other,MM-Memorandum of Meeting,2000-04-27T04:00:00Z,2000,4,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4c7
FDA-1995-S-0039-0169,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),2000-04-19T04:00:00Z,2000,4,2009-02-05T05:00:00Z,,2016-09-30T14:23:12Z,,0,0,090000648055c40d
FDA-1995-S-0039-0168,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),2000-04-18T04:00:00Z,2000,4,2009-02-05T05:00:00Z,,2016-09-30T14:23:11Z,,0,0,090000648055c40b
FDA-1980-P-0012-0014,FDA,FDA-1980-P-0012,"Approval for Variance from FDA/CDRH to Showlasers, Inc. (duplicate)",Other,Approval for Variance (VRA),2000-04-13T04:00:00Z,2000,4,,,2021-02-24T17:53:01Z,,0,0,09000064805b926d
FDA-1980-P-0012-0013,FDA,FDA-1980-P-0012,"Approval for Variance from FDA/CDRH to Showlasers, Inc.",Other,Approval for Variance (VRA),2000-04-13T04:00:00Z,2000,4,,,2021-02-24T17:51:26Z,,0,0,09000064805b926c
FDA-2000-P-0024-0001,FDA,FDA-2000-P-0024,FDA/DDM to Pharmaceutical Associates Inc,Other,ACK-Acknowledgement Letter,2000-04-07T04:00:00Z,2000,4,,,2008-04-25T01:13:49Z,,0,0,09000064804ae9e8
FDA-1999-P-0126-0006,FDA,FDA-1999-P-0126,FDA/CDER to Pharmacia & Upjohn,Other,LET-Letter,2000-04-06T04:00:00Z,2000,4,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9f2
FDA-1999-P-0059-0002,FDA,FDA-1999-P-0059,FDA/CDRH to Sanford J. Lewis,Other,LET-Letter,2000-04-06T04:00:00Z,2000,4,,,2008-04-25T00:13:57Z,,0,0,09000064804a6715
FDA-1986-V-0022-0009,FDA,FDA-1986-V-0022,Variance Approval Letter from FDA CDRH to California Technical Associates,Other,Approval for Variance (VRA),2000-03-22T05:00:00Z,2000,3,,,2023-01-18T18:47:01Z,,0,0,090000648050dd45
FDA-1991-V-0023-0005,FDA,FDA-1991-V-0023,Variance Approval Letter from FDA CDRH to Las Vegas Laser Rental,Other,Approval for Variance (VRA),2000-03-22T05:00:00Z,2000,3,,,2023-10-13T12:19:38Z,,0,0,0900006480528680
FDA-2000-P-0025-0001,FDA,FDA-2000-P-0025,Acknowledgment Letter from FDA DMB to American Orthotic & Prosthetic Association,Other,ACK-Acknowledgement Letter,2000-03-14T05:00:00Z,2000,3,,,2024-07-29T20:12:00Z,,0,0,09000064804aea0c
FDA-2000-D-1542-0002,FDA,FDA-2000-D-1542,Draft Guidance for Industry on the Content and Format of New Drug Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug Products - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2000-03-10T19:46:00Z,2000,3,2000-03-10T05:00:00Z,,2019-10-17T17:11:55Z,,0,0,09000064804f9073
FDA-1995-S-0039-0167,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),2000-02-17T05:00:00Z,2000,2,2009-02-05T05:00:00Z,,2016-09-30T14:23:11Z,,0,0,090000648055c402
FDA-1995-S-0039-0166,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),2000-02-17T05:00:00Z,2000,2,2009-02-05T05:00:00Z,,2016-09-30T14:23:11Z,,0,0,090000648055c3fe
FDA-2000-P-0211-0001,FDA,FDA-2000-P-0211,FDA/DDM to Mark S. Zaid,Other,ACK-Acknowledgement Letter,2000-02-16T05:00:00Z,2000,2,,,2008-04-25T01:47:40Z,,0,0,09000064804d4c9f
FDA-1998-P-0018-0003,FDA,FDA-1998-P-0018,Correction to Citizen Petition from King & Spalding,Other,Correction(s),2000-02-14T05:00:00Z,2000,2,,,2024-07-12T16:52:34Z,,0,0,0900006480563c52
FDA-1999-D-0061-0003,FDA,FDA-1999-D-0061,HFZ-220,Other,NAD-Notice of Availability of Data,2000-02-03T05:00:00Z,2000,2,,,2024-11-07T21:52:50Z,,1,0,09000064804a6774
FDA-1996-N-0006-0003,FDA,FDA-1996-N-0006,"Memorandum of Meeting FDA with European Sunscreen Manufacturers re Sunscreen Monograph/Foreign Marketing October 28, 1998",Other,Memorandum,2000-01-20T05:00:00Z,2000,1,,,2015-03-20T16:01:26Z,,0,0,09000064804f9943
FDA-2020-D-1957-0001,FDA,FDA-2020-D-1957,CPG Sec. 300.200 - Reconditioners/Rebuilders of Medical Devices - Revoked-Deletion 01/04/2000,Other,Guidance,2000-01-03T05:00:00Z,2000,1,2020-09-21T04:00:00Z,,2024-11-06T23:39:28Z,,1,0,0900006484869390
FDA-1995-S-0039-0157,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),2000-01-01T05:00:00Z,2000,1,2009-01-02T05:00:00Z,,2016-09-30T14:23:07Z,,0,0,090000648055c3f8